Medicskin Holdings Limited disclosed in its Monthly Return for Equity Issuer that no changes occurred in its share capital structure during June 2026.

Authorised and issued share capital • Authorised share capital remained at 1.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 10.00 million. • Issued share capital stayed unchanged at 396.74 million ordinary shares; the company held no treasury shares. • Consequently, total issued shares and the public float position were unchanged, and the company confirmed compliance with the minimum 25% public-float requirement on the GEM board.

Share option scheme update • Under the Share Option Scheme adopted on 27 September 2024, 39.67 million options were outstanding at month-end, representing the maximum number of shares that may be issued upon exercise. • No options were exercised, no new shares were issued, and no treasury shares were transferred during the period. • No warrants, convertibles, or other equity-linked instruments were outstanding or issued in the month.

Liquidity and governance confirmation • The company affirmed it had met all Hong Kong Listing Rules requirements, received all monies due from any securities activities, and had no discrepancies in share classes.

Overall, Medicskin ended June 2026 with an unchanged capital base and a sizeable pool of unexercised share options, positioning it for future equity-based incentive activities without immediate dilution to existing shareholders.